Match!
Finn Børlum Kristensen
University of Southern Denmark
Environmental resource managementHealth careHealth technologyHealth policyMedicine
36Publications
12H-index
489Citations
What is this?
Publications 33
Newest
Introduction: Implementation of health technology assessment (HTA) is still in an early stage with some heterogeneity in the Middle East and North Africa (MENA). Our objective was to assess the current and future status of HTA implementation in the MENA region by focusing on regional commonalities. Methods: Preparatory discussions for the first ISPOR conference in the MENA region indicated some potentially generalizable trends of HTA roadmaps. To widen the perspective, a policy survey was conduc...
Source
#1Tomas Tesar (Comenius University in Bratislava)H-Index: 6
#2Branislav ObsitnikH-Index: 1
Last. Finn Børlum Kristensen (University of Southern Denmark)H-Index: 12
view all 4 authors...
Objectives: The aim of this study was to review the impact of new reimbursement requirements for medicines in the Slovak Republic based on legislation that came into force in January 2018. Methods: The new legislation was reviewed. The reimbursement dossiers for medicines and health technology assessments and appraisals, justifications for reimbursement decisions, final reimbursement decisions, and all aspects of the appeal mechanisms have been transparently published on the website of the Slova...
1 CitationsSource
#1A.N. FasseehH-Index: 1
Last. Z. KalóH-Index: 2
view all 13 authors...
Source
#1Finn Børlum Kristensen (University of Southern Denmark)H-Index: 12
#2Don Husereau (U of O: University of Ottawa)H-Index: 20
Last. Allan Wailoo (University of Sheffield)H-Index: 30
view all 17 authors...
The systematic use of evidence to inform healthcare decisions, particularly health technology assessment (HTA), has gained increased recognition. HTA has become a standard policy tool for informing decision makers who must manage the entry and use of pharmaceuticals, medical devices, and other technologies (including complex interventions) within health systems, for example, through reimbursement and pricing. Despite increasing attention to HTA activities, there has been no attempt to comprehens...
5 CitationsSource
Last. Louis P. Garrison (UW: University of Washington)H-Index: 29
view all 4 authors...
Abstract In February and September of 2017, the International Society for Pharmacoeconomics and Outcomes Research Health Technology Assessment Council held roundtables focused on Latin America to discuss health technology assessment best practices, collaboration opportunities, and regional experiences regarding health policies to improve the affordability of and access to healthcare technologies. The access to high-cost technologies, increased social pressure to achieve universal coverage, popul...
Source
2 CitationsSource
#3Helga SigmundH-Index: 6
Health Technology Assessment Handbook , Health Technology Assessment Handbook , کتابخانه مرکزی دانشگاه علوم پزشکی ایران
10 Citations
#1Finn Børlum Kristensen (University of Southern Denmark)H-Index: 12
#2Kristian LampeH-Index: 5
Last. Lidia BeclaH-Index: 1
view all 6 authors...
Abstract Background and Objectives The HTA Core Model ® as a science-based framework for assessing dimensions of value was developed as a part of the European network for Health Technology Assessment project in the period 2006 to 2008 to facilitate production and sharing of health technology assessment (HTA) information, such as evidence on efficacy and effectiveness and patient aspects, to inform decisions. Methods It covers clinical value as well as organizational, economic, and patient aspect...
16 CitationsSource
#1Zoltán Kaló (ELTE: Eötvös Loránd University)H-Index: 18
#2Marcell CsanádiH-Index: 6
Last. Finn Børlum KristensenH-Index: 12
view all 6 authors...
1 CitationsSource
Results The results of the questionnaire showed that, 7 months after sofosbuvir received market authorisation, in 11 countries the assessment of the effectiveness sofosbuvir had not yet started, in nine it was ongoing and in seven it was completed. Of the 11 countries that had not started an assessment, five Eastern European countries reported that the MAH had not yet submitted an application for reimbursement of sofosbuvir. The analysis also showed that in the seven reports from different Europ...
1 CitationsSource
1234